Journal: Bioorganic & medicinal chemistry letters

Article Title: Structure guided design of a series of selective pyrrolopyrimidinone MARK inhibitors.

PMID/MRN: 27816515

Publication Date: 2017-Jan-01

Abstract:

The initial structure activity relationships around an isoindoline uHTS hit will be described. Information gleaned from ligand co-crystal structures allowed for rapid refinements in both MARK potency and kinase selectivity. These efforts allowed for the identification of a compound with properties suitable for use as an in vitro tool compound for validation studies on MARK as a viable target for Alzheimer's disease. Copyright å© 2016 Elsevier Ltd. All rights reserved.